25 XP   0   0   10

Taro Pharmaceutical Industries Ltd
Buy, Hold or Sell?

Let's analyse Taro together

PenkeI guess you are interested in Taro Pharmaceutical Industries Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Taro Pharmaceutical Industries Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Taro Pharmaceutical Industries Ltd

I send you an email if I find something interesting about Taro Pharmaceutical Industries Ltd.

Quick analysis of Taro (30 sec.)










What can you expect buying and holding a share of Taro? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$47.34
Expected worth in 1 year
$48.91
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
$1.57
Return On Investment
3.7%

For what price can you sell your share?

Current Price per Share
$42.26
Expected price per share
$40.67 - $45.76
How sure are you?
50%

1. Valuation of Taro (5 min.)




Live pricePrice per Share (EOD)

$42.26

Intrinsic Value Per Share

$-48.46 - $8.47

Total Value Per Share

$-1.12 - $55.81

2. Growth of Taro (5 min.)




Is Taro growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7b$1.7b$36.7m2.1%

How much money is Taro making?

Current yearPrevious yearGrowGrow %
Making money$11.4m$14.8m-$3.3m-29.7%
Net Profit Margin7.4%10.3%--

How much money comes from the company's main activities?

3. Financial Health of Taro (5 min.)




What can you expect buying and holding a share of Taro? (5 min.)

Welcome investor! Taro's management wants to use your money to grow the business. In return you get a share of Taro.

What can you expect buying and holding a share of Taro?

First you should know what it really means to hold a share of Taro. And how you can make/lose money.

Speculation

The Price per Share of Taro is $42.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Taro.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Taro, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $47.34. Based on the TTM, the Book Value Change Per Share is $0.39 per quarter. Based on the YOY, the Book Value Change Per Share is $0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Taro.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.541.3%0.300.7%0.310.7%0.050.1%1.232.9%
Usd Book Value Change Per Share0.842.0%0.390.9%0.160.4%0.000.0%0.651.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.651.5%0.651.5%
Usd Total Gains Per Share0.842.0%0.390.9%0.160.4%0.651.5%1.303.1%
Usd Price Per Share41.78-35.44-34.61-57.62-90.90-
Price to Earnings Ratio19.43-32.33--5.90-9.37-12.81-
Price-to-Total Gains Ratio49.79-119.08--9.70-43.54-120.95-
Price to Book Ratio0.88-0.76-0.76-1.21-2.19-
Price-to-Total Gains Ratio49.79-119.08--9.70-43.54-120.95-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share42.26
Number of shares23
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.65
Usd Book Value Change Per Share0.390.00
Usd Total Gains Per Share0.390.65
Gains per Quarter (23 shares)9.0514.85
Gains per Year (23 shares)36.2059.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10362660-049
207262119-1108
3010998179-1167
40145134239-1226
50181170298-1285
60217206358-2344
70253242418-2403
80290278477-2462
90326314537-2521
100362350597-3580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%16.04.00.080.0%36.04.00.090.0%84.04.01.094.4%
Book Value Change Per Share4.00.00.0100.0%8.03.01.066.7%15.04.01.075.0%32.05.03.080.0%73.012.04.082.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%2.00.038.05.0%2.00.087.02.2%
Total Gains per Share4.00.00.0100.0%8.03.01.066.7%15.04.01.075.0%33.04.03.082.5%74.011.04.083.1%

Fundamentals of Taro

About Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

Fundamental data was last updated by Penke on 2024-03-14 11:22:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Taro Pharmaceutical Industries Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Taro earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.9% means that $0.13 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 12.9%. The company is making a huge profit. +2
  • The TTM is 7.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ12.9%TTM7.4%+5.4%
TTM7.4%YOY10.3%-2.9%
TTM7.4%5Y-2.7%+10.1%
5Y-2.7%10Y23.3%-26.0%
1.1.2. Return on Assets

Shows how efficient Taro is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.9% Return on Assets means that Taro generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.5%+0.4%
TTM0.5%YOY0.7%-0.1%
TTM0.5%5Y0.2%+0.3%
5Y0.2%10Y2.9%-2.7%
1.1.3. Return on Equity

Shows how efficient Taro is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Equity means Taro generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM0.7%+0.5%
TTM0.7%YOY0.9%-0.2%
TTM0.7%5Y0.0%+0.7%
5Y0.0%10Y3.3%-3.3%

1.2. Operating Efficiency of Taro Pharmaceutical Industries Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Taro is operating .

  • Measures how much profit Taro makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 10.0% means the company generated $0.10  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 10.0%. The company is operating less efficient.
  • The TTM is 3.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.0%TTM3.6%+6.4%
TTM3.6%YOY3.5%+0.0%
TTM3.6%5Y44.7%-41.1%
5Y44.7%10Y48.4%-3.8%
1.2.2. Operating Ratio

Measures how efficient Taro is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.90 means that the operating costs are $0.90 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.899. The company is less efficient in keeping operating costs low.
  • The TTM is 0.963. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.899TTM0.963-0.064
TTM0.963YOY0.936+0.027
TTM0.9635Y0.792+0.171
5Y0.79210Y0.618+0.174

1.3. Liquidity of Taro Pharmaceutical Industries Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Taro is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.60 means the company has $3.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 3.602. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.536. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.602TTM3.536+0.066
TTM3.536YOY3.382+0.154
TTM3.5365Y4.035-0.499
5Y4.03510Y5.555-1.521
1.3.2. Quick Ratio

Measures if Taro is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 4.42 means the company can pay off $4.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 4.417. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.651. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.417TTM4.651-0.234
TTM4.651YOY4.429+0.222
TTM4.6515Y5.100-0.449
5Y5.10010Y7.137-2.037

1.4. Solvency of Taro Pharmaceutical Industries Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Taro assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Taro to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.18 means that Taro assets are financed with 17.8% credit (debt) and the remaining percentage (100% - 17.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.178. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.182. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.178TTM0.182-0.005
TTM0.182YOY0.201-0.019
TTM0.1825Y0.197-0.015
5Y0.19710Y0.163+0.034
1.4.2. Debt to Equity Ratio

Measures if Taro is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 21.6% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.216. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.223. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.223-0.007
TTM0.223YOY0.252-0.030
TTM0.2235Y0.254-0.032
5Y0.25410Y0.203+0.051

2. Market Valuation of Taro Pharmaceutical Industries Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Taro generates.

  • Above 15 is considered overpriced but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 19.43 means the investor is paying $19.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The EOD is 19.650. Based on the earnings, the company is fair priced.
  • The MRQ is 19.427. Based on the earnings, the company is fair priced.
  • The TTM is 32.330. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD19.650MRQ19.427+0.223
MRQ19.427TTM32.330-12.903
TTM32.330YOY-5.904+38.234
TTM32.3305Y9.373+22.957
5Y9.37310Y12.809-3.437
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The EOD is -111.760. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -110.491. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 71.249. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-111.760MRQ-110.491-1.269
MRQ-110.491TTM71.249-181.740
TTM71.249YOY22.291+48.958
TTM71.2495Y24.649+46.600
5Y24.64910Y20.027+4.623
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Taro is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The EOD is 0.893. Based on the equity, the company is cheap. +2
  • The MRQ is 0.883. Based on the equity, the company is cheap. +2
  • The TTM is 0.760. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.893MRQ0.883+0.010
MRQ0.883TTM0.760+0.122
TTM0.760YOY0.760+0.001
TTM0.7605Y1.214-0.454
5Y1.21410Y2.192-0.978
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Taro Pharmaceutical Industries Ltd.

3.1. Institutions holding Taro Pharmaceutical Industries Ltd

Institutions are holding 13.463% of the shares of Taro Pharmaceutical Industries Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Krensavage Asset Management, LLC1.729.582764645357180.8924
2023-12-31BlackRock Inc1.65750.0007622983410937.062
2023-12-31Renaissance Technologies Corp1.54160.0375579400-9400-1.5965
2023-12-31Dimensional Fund Advisors, Inc.1.45190.0067545682-4226-0.7685
2023-12-31Brandes Investment Partners & Co1.26580.301747574132530.6885
2023-09-30Ameriprise Financial Inc0.80970.00383043097405432.1617
2023-12-31Eversept Partners, LLC0.68110.93962559886650.2605
2023-12-31Amvescap Plc.0.62920.0024236486-28569-10.7785
2023-09-30State Street Corporation0.4260.00031601105840.3661
2023-09-30Murchinson Ltd.0.2760.501910374400
2023-09-30Geode Capital Management, LLC0.23540.00048847359377.1932
2023-09-30COWEN AND COMPANY, LLC0.1840.182569160-1446-2.048
2023-09-30Verition Fund Managegment, LLC0.17980.029767584675840
2023-09-30Northern Trust Corp0.15420.0004579415260.9161
2023-09-30ARK Investment Management LLC0.15320.016657561-24058-29.476
2023-09-30UBS Group AG0.14410.0007541751958856.634
2023-09-30Morgan Stanley - Brokerage Accounts0.14130.00025309229392124.0169
2023-09-30Vanguard Group Inc0.127904805210932.3276
2023-12-31NORGES BANK0.1140.000342835-17955-29.5361
2023-12-31Arrowstreet Capital Limited Partnership0.10520.001739556-31314-44.1851
Total 11.997911.60984509325+132519+2.9%

3.2. Funds holding Taro Pharmaceutical Industries Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-01iShares Russell 2000 ETF0.54040.0144203108-1353-0.6617
2023-12-31Columbia Small Cap Value I0.53140.611219971223001.1651
2024-01-31Columbia Small Cap Value I A0.47220.5823177492-22220-11.126
2024-01-31Brandes International Small Cap Eq0.28541.027410727300
2024-01-31DSP Healthcare Fund Reg Gr0.23811.46878947500
2023-12-31Fidelity Small Cap Index0.21650.0134813859151.1371
2023-12-31Brandes International Small Cap Equity A0.21520.79548087000
2024-02-01iShares Russell 2000 Value ETF0.2090.0286785341000.1275
2024-01-31DFA US Core Equity 2 I0.20670.010577682-2940-3.6466
2024-01-31Brandes Global Small-Mid Cap Equity0.193.53557140500
2024-01-31Columbia VP Small Cap Value 10.18620.581669966-9960-12.4615
2024-01-31DFA US Core Equity 1 I0.15470.007858126-2923-4.788
2024-02-29ARK Israel Innovative Technology ETF0.13621.91015117200
2024-02-27iShares Core MSCI EAFE ETF0.13410.00195039400
2024-01-31DFA US Micro Cap I0.13210.03144965700
2024-01-31DFA US Targeted Value I0.13150.01654941800
2024-01-31DFA US Small Cap I0.12060.01334532200
2024-02-29Dimensional US Core Equity 2 ETF0.10120.00613801700
2024-02-28iShares MSCI EAFE Small-Cap ETF0.09420.01513539600
2024-01-31Brandes Global Opportunities F0.08771.034832974-6477-16.4178
Total 4.383411.7061647378-42558-2.6%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Taro Pharmaceutical Industries Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8390.393+113%0.156+440%-0.003+100%0.652+29%
Book Value Per Share--47.33546.535+2%45.558+4%47.163+0%45.399+4%
Current Ratio--3.6023.536+2%3.382+7%4.035-11%5.555-35%
Debt To Asset Ratio--0.1780.182-2%0.201-12%0.197-10%0.163+9%
Debt To Equity Ratio--0.2160.223-3%0.252-14%0.254-15%0.203+6%
Dividend Per Share----0%-0%0.649-100%0.645-100%
Eps--0.5380.305+76%0.306+76%0.051+953%1.228-56%
Free Cash Flow Per Share---0.0950.572-117%0.671-114%0.389-124%1.380-107%
Free Cash Flow To Equity Per Share---0.0950.572-117%1.003-109%0.325-129%0.722-113%
Gross Profit Margin--1.0000.475+110%1.0000%0.895+12%0.948+6%
Intrinsic Value_10Y_max--8.473--------
Intrinsic Value_10Y_min---48.460--------
Intrinsic Value_1Y_max--4.851--------
Intrinsic Value_1Y_min---0.644--------
Intrinsic Value_3Y_max--11.526--------
Intrinsic Value_3Y_min---5.595--------
Intrinsic Value_5Y_max--14.524--------
Intrinsic Value_5Y_min---14.519--------
Market Cap1588325196.000+1%1570296745.9801331820612.585+18%1300813077.510+21%2193887857.998-28%3682901019.502-57%
Net Profit Margin--0.1290.074+73%0.103+24%-0.027+121%0.233-45%
Operating Margin--0.1000.036+179%0.035+183%0.447-78%0.484-79%
Operating Ratio--0.8990.963-7%0.936-4%0.792+13%0.618+45%
Pb Ratio0.893+1%0.8830.760+16%0.760+16%1.214-27%2.192-60%
Pe Ratio19.650+1%19.42732.330-40%-5.904+130%9.373+107%12.809+52%
Price Per Share42.260+1%41.78035.435+18%34.610+21%57.624-27%90.900-54%
Price To Free Cash Flow Ratio-111.760-1%-110.49171.249-255%22.291-596%24.649-548%20.027-652%
Price To Total Gains Ratio50.364+1%49.792119.077-58%-9.703+119%43.543+14%120.954-59%
Quick Ratio--4.4174.651-5%4.4290%5.100-13%7.137-38%
Return On Assets--0.0090.005+75%0.007+37%0.002+408%0.029-67%
Return On Equity--0.0110.007+75%0.009+31%0.000+101%0.033-65%
Total Gains Per Share--0.8390.393+113%0.156+440%0.646+30%1.297-35%
Usd Book Value--1779093000.0001749009750.000+2%1712275250.000+4%1790370300.000-1%1792323800.000-1%
Usd Book Value Change Per Share--0.8390.393+113%0.156+440%-0.003+100%0.652+29%
Usd Book Value Per Share--47.33546.535+2%45.558+4%47.163+0%45.399+4%
Usd Dividend Per Share----0%-0%0.649-100%0.645-100%
Usd Eps--0.5380.305+76%0.306+76%0.051+953%1.228-56%
Usd Free Cash Flow---3553000.00021500250.000-117%25212000.000-114%14979050.000-124%56787900.000-106%
Usd Free Cash Flow Per Share---0.0950.572-117%0.671-114%0.389-124%1.380-107%
Usd Free Cash Flow To Equity Per Share---0.0950.572-117%1.003-109%0.325-129%0.722-113%
Usd Market Cap1588325196.000+1%1570296745.9801331820612.585+18%1300813077.510+21%2193887857.998-28%3682901019.502-57%
Usd Price Per Share42.260+1%41.78035.435+18%34.610+21%57.624-27%90.900-54%
Usd Profit--20208000.00011425250.000+77%14815000.000+36%2592350.000+680%53743075.000-62%
Usd Revenue--157145000.000152707000.000+3%139057000.000+13%147939950.000+6%176919750.000-11%
Usd Total Gains Per Share--0.8390.393+113%0.156+440%0.646+30%1.297-35%
 EOD+5 -3MRQTTM+25 -9YOY+24 -95Y+20 -1610Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Taro Pharmaceutical Industries Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.650
Price to Book Ratio (EOD)Between0-10.893
Net Profit Margin (MRQ)Greater than00.129
Operating Margin (MRQ)Greater than00.100
Quick Ratio (MRQ)Greater than14.417
Current Ratio (MRQ)Greater than13.602
Debt to Asset Ratio (MRQ)Less than10.178
Debt to Equity Ratio (MRQ)Less than10.216
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.009
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Taro Pharmaceutical Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.576
Ma 20Greater thanMa 5042.050
Ma 50Greater thanMa 10042.270
Ma 100Greater thanMa 20040.448
OpenGreater thanClose42.240
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,163,179
Total Liabilities384,086
Total Stockholder Equity1,779,093
 As reported
Total Liabilities 384,086
Total Stockholder Equity+ 1,779,093
Total Assets = 2,163,179

Assets

Total Assets2,163,179
Total Current Assets1,347,404
Long-term Assets815,775
Total Current Assets
Cash And Cash Equivalents 382,409
Short-term Investments 519,807
Net Receivables 230,372
Inventory 214,816
Total Current Assets  (as reported)1,347,404
Total Current Assets  (calculated)1,347,404
+/-0
Long-term Assets
Property Plant Equipment 218,385
Goodwill 17,231
Long Term Investments 403,544
Long-term Assets Other 79,315
Long-term Assets  (as reported)815,775
Long-term Assets  (calculated)718,475
+/- 97,300

Liabilities & Shareholders' Equity

Total Current Liabilities374,059
Long-term Liabilities10,027
Total Stockholder Equity1,779,093
Total Current Liabilities
Accounts payable 51,183
Other Current Liabilities 322,876
Total Current Liabilities  (as reported)374,059
Total Current Liabilities  (calculated)374,059
+/-0
Long-term Liabilities
Long-term Liabilities Other 10,027
Long-term Liabilities  (as reported)10,027
Long-term Liabilities  (calculated)10,027
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)1,779,093
Total Stockholder Equity (calculated)0
+/- 1,779,093
Other
Cash and Short Term Investments 902,216
Common Stock Shares Outstanding 37,585
Liabilities and Stockholders Equity 2,163,179
Net Debt -382,409
Net Invested Capital 1,779,093
Net Working Capital 973,345



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302007-12-312007-09-302006-12-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-31
> Total Assets 
0
0
0
7,300
0
0
0
7,900
0
0
0
9,600
9,300
0
0
11,200
11,800
12,600
13,600
14,700
17,900
19,700
22,200
25,600
0
0
0
33,800
0
0
0
42,800
0
0
0
49,500
52,400
56,800
58,100
61,900
63,800
66,300
70,600
73,100
77,300
0
0
74,600
75,600
84,800
89,600
90,957
95,953
99,511
115,280
120,446
123,754
140,959
152,004
307,762
316,635
337,917
346,712
379,845
429,779
498,118
527,046
616,523
639,226
635,108
659,759
696,847
693,208
702,541
710,230
579,011
424,690
486,451
483,400
497,300
507,198
473,098
467,120
477,941
524,721
575,889
579,011
520,254
545,207
556,442
597,581
636,816
713,916
795,845
856,424
876,185
966,382
1,045,308
1,106,636
1,106,636
1,291,911
1,205,024
1,284,376
1,284,376
1,447,923
1,599,018
1,737,745
1,737,745
1,901,491
2,070,473
2,188,033
2,168,323
2,150,779
2,247,179
2,289,753
2,357,647
2,413,817
2,421,889
2,433,210
2,477,889
2,555,506
2,069,518
2,135,326
2,172,200
2,249,706
2,290,963
2,341,252
2,379,693
2,346,108
2,371,824
2,406,873
2,413,305
2,317,158
2,123,019
2,176,361
2,176,361
2,107,279
2,117,524
2,135,513
2,135,049
2,119,473
2,163,179
2,163,1792,119,4732,135,0492,135,5132,117,5242,107,2792,176,3612,176,3612,123,0192,317,1582,413,3052,406,8732,371,8242,346,1082,379,6932,341,2522,290,9632,249,7062,172,2002,135,3262,069,5182,555,5062,477,8892,433,2102,421,8892,413,8172,357,6472,289,7532,247,1792,150,7792,168,3232,188,0332,070,4731,901,4911,737,7451,737,7451,599,0181,447,9231,284,3761,284,3761,205,0241,291,9111,106,6361,106,6361,045,308966,382876,185856,424795,845713,916636,816597,581556,442545,207520,254579,011575,889524,721477,941467,120473,098507,198497,300483,400486,451424,690579,011710,230702,541693,208696,847659,759635,108639,226616,523527,046498,118429,779379,845346,712337,917316,635307,762152,004140,959123,754120,446115,28099,51195,95390,95789,60084,80075,60074,6000077,30073,10070,60066,30063,80061,90058,10056,80052,40049,50000042,80000033,80000025,60022,20019,70017,90014,70013,60012,60011,80011,200009,3009,6000007,9000007,300000
   > Total Current Assets 
0
0
0
4,500
0
0
0
4,700
0
0
0
5,600
5,300
0
0
7,000
7,600
8,100
8,900
10,100
12,600
13,100
15,000
15,100
0
0
0
17,700
0
0
0
25,000
0
0
0
27,900
29,500
31,900
31,700
33,000
34,200
35,900
40,200
38,900
42,000
0
0
39,700
40,500
47,500
51,500
50,725
53,977
56,257
70,968
71,738
72,123
86,825
94,018
231,494
235,302
242,977
239,386
257,115
258,038
309,479
328,225
383,693
363,063
337,129
312,177
333,114
311,813
322,586
322,763
221,698
0
0
208,400
0
244,558
226,630
232,620
244,357
280,956
289,504
221,698
294,330
314,559
295,637
344,725
395,511
488,231
581,431
653,661
678,716
770,824
841,672
909,771
909,771
1,096,366
978,365
1,051,271
1,051,271
1,214,763
1,351,573
1,513,807
1,513,807
1,708,424
1,865,170
1,877,595
1,685,126
1,579,041
1,781,875
1,999,024
1,934,056
1,927,085
1,906,923
1,896,635
1,833,199
1,865,004
1,461,748
1,482,720
1,533,655
1,479,866
1,457,710
1,532,598
1,522,936
1,485,830
1,522,274
1,470,835
1,480,767
1,411,947
1,237,238
1,337,886
1,337,886
1,356,608
1,390,110
1,336,428
1,294,173
1,342,555
1,347,404
1,347,4041,342,5551,294,1731,336,4281,390,1101,356,6081,337,8861,337,8861,237,2381,411,9471,480,7671,470,8351,522,2741,485,8301,522,9361,532,5981,457,7101,479,8661,533,6551,482,7201,461,7481,865,0041,833,1991,896,6351,906,9231,927,0851,934,0561,999,0241,781,8751,579,0411,685,1261,877,5951,865,1701,708,4241,513,8071,513,8071,351,5731,214,7631,051,2711,051,271978,3651,096,366909,771909,771841,672770,824678,716653,661581,431488,231395,511344,725295,637314,559294,330221,698289,504280,956244,357232,620226,630244,5580208,40000221,698322,763322,586311,813333,114312,177337,129363,063383,693328,225309,479258,038257,115239,386242,977235,302231,49494,01886,82572,12371,73870,96856,25753,97750,72551,50047,50040,50039,7000042,00038,90040,20035,90034,20033,00031,70031,90029,50027,90000025,00000017,70000015,10015,00013,10012,60010,1008,9008,1007,6007,000005,3005,6000004,7000004,500000
       Cash And Cash Equivalents 
0
0
0
900
0
0
0
100
0
0
0
700
300
0
0
300
400
300
400
600
1,600
600
5,300
200
0
0
0
1,300
0
0
0
1,300
0
0
0
800
2,500
2,400
2,600
600
2,700
2,500
2,500
800
2,600
0
0
1,100
800
700
900
3,003
2,100
2,676
1,271
7,245
1,779
3,108
15,870
153,148
143,734
133,483
135,132
130,717
121,857
152,780
136,856
159,121
106,360
94,161
91,185
98,630
78,010
78,665
76,740
72,828
16,140
50,097
45,200
0
66,253
68,828
80,755
72,862
81,704
93,307
72,828
86,309
89,477
85,144
119,977
149,345
206,151
239,815
310,706
342,564
408,705
276,995
237,284
237,284
350,611
207,455
209,967
209,967
258,615
283,219
481,641
481,641
487,695
523,214
576,757
438,732
365,638
549,646
600,399
430,713
503,321
569,193
576,611
641,989
825,600
566,469
567,451
632,986
560,667
509,361
513,354
532,044
498,796
552,918
605,177
614,888
523,668
318,103
251,134
251,134
175,191
91,973
154,495
124,165
269,011
382,409
382,409269,011124,165154,49591,973175,191251,134251,134318,103523,668614,888605,177552,918498,796532,044513,354509,361560,667632,986567,451566,469825,600641,989576,611569,193503,321430,713600,399549,646365,638438,732576,757523,214487,695481,641481,641283,219258,615209,967209,967207,455350,611237,284237,284276,995408,705342,564310,706239,815206,151149,345119,97785,14489,47786,30972,82893,30781,70472,86280,75568,82866,253045,20050,09716,14072,82876,74078,66578,01098,63091,18594,161106,360159,121136,856152,780121,857130,717135,132133,483143,734153,14815,8703,1081,7797,2451,2712,6762,1003,0039007008001,100002,6008002,5002,5002,7006002,6002,4002,5008000001,3000001,3000002005,3006001,60060040030040030000300700000100000900000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,307
0
0
0
2,416
0
0
0
2,468
0
0
0
2,518
0
0
0
13,300
0
0
0
6,859
114
41
0
0
0
10,000
6,250
6,250
29,313
20,974
21,000
2,695
5,156
3,693
3,684
2,786
2,889
2,901
7,835
3,043
3,110
202,145
315,786
315,786
360,284
366,003
422,201
422,201
423,697
454,574
438,357
438,357
574,629
659,484
651,869
536,145
543,838
558,549
786,361
1,014,270
895,565
822,585
846,009
771,691
596,744
488,582
481,883
506,751
496,948
542,032
595,383
590,286
543,204
521,041
418,480
410,590
448,895
468,976
569,614
569,614
664,301
771,925
695,794
681,988
638,038
519,807
519,807638,038681,988695,794771,925664,301569,614569,614468,976448,895410,590418,480521,041543,204590,286595,383542,032496,948506,751481,883488,582596,744771,691846,009822,585895,5651,014,270786,361558,549543,838536,145651,869659,484574,629438,357438,357454,574423,697422,201422,201366,003360,284315,786315,786202,1453,1103,0437,8352,9012,8892,7863,6843,6935,1562,69521,00020,97429,3136,2506,25010,000000411146,85900013,3000002,5180002,4680002,4160002,3070000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
1,800
0
0
0
2,600
0
0
0
2,600
2,800
0
0
4,100
4,600
4,700
5,200
5,900
6,600
7,400
9,100
7,600
0
0
0
9,100
0
0
0
13,300
0
0
0
14,200
15,500
17,300
16,500
17,400
16,900
19,900
25,000
21,400
21,300
0
0
21,900
21,100
27,100
25,100
27,405
30,680
32,829
40,132
40,490
44,232
52,278
48,031
49,265
57,929
70,825
65,968
69,038
82,938
92,555
120,450
120,522
155,712
134,433
116,128
124,674
146,389
158,168
160,274
65,819
0
0
96,300
0
107,306
81,703
78,968
99,723
103,017
107,246
107,200
98,508
101,838
122,657
134,578
152,000
185,867
215,176
209,631
222,014
241,620
244,301
239,578
239,578
273,358
285,012
301,164
301,164
406,391
488,435
473,338
473,338
519,178
554,563
509,335
561,246
518,900
526,726
470,204
343,636
378,008
365,959
329,420
278,485
289,553
258,650
285,307
245,635
273,812
248,442
270,788
234,383
276,617
278,788
266,886
272,429
256,456
267,713
306,699
306,699
301,592
251,807
259,470
283,428
227,318
230,372
230,372227,318283,428259,470251,807301,592306,699306,699267,713256,456272,429266,886278,788276,617234,383270,788248,442273,812245,635285,307258,650289,553278,485329,420365,959378,008343,636470,204526,726518,900561,246509,335554,563519,178473,338473,338488,435406,391301,164301,164285,012273,358239,578239,578244,301241,620222,014209,631215,176185,867152,000134,578122,657101,83898,508107,200107,246103,01799,72378,96881,703107,306096,3000065,819160,274158,168146,389124,674116,128134,433155,712120,522120,45092,55582,93869,03865,96870,82557,92949,26548,03152,27844,23240,49040,13232,82930,68027,40525,10027,10021,10021,9000021,30021,40025,00019,90016,90017,40016,50017,30015,50014,20000013,3000009,1000007,6009,1007,4006,6005,9005,2004,7004,6004,100002,8002,6000002,6000001,800000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-100
0
-100
0
1,600
0
0
0
1,500
0
0
0
1,700
0
0
0
1,700
-100
-100
0
1,900
0
0
0
1,900
0
0
0
2,000
2,000
2,100
6,300
2,109
2,136
2,172
10,052
2,307
2,606
2,300
3,500
2,400
2,500
2,500
2,500
12,453
2,480
2,516
2,516
7,642
6,850
6,870
6,581
6,561
6,796
6,750
6,738
6,859
19,192
15,309
-100
0
35,269
11,262
6,250
6,250
29,313
43,505
72,678
26,295
37,250
434
462
470
441
16,161
15,851
7,046
7,498
7,499
124,513
124,513
71
73
140,865
140,865
282
268
210,785
210,785
1,066
1,034
226,228
1,058
1,062
999
145,313
1,083
934,129
-100
7,707
625,608
65,546
0
8,137
0
0
0
8,506
234,383
276,617
0
14,025
272,429
292,029
303,286
14,220
14,220
53,097
51,730
-1
56,555
46,254
39,140
39,14046,25456,555-151,73053,09714,22014,220303,286292,029272,42914,0250276,617234,3838,5060008,137065,546625,6087,707-100934,1291,083145,3139991,0621,058226,2281,0341,066210,785210,785268282140,865140,8657371124,513124,5137,4997,4987,04615,85116,16144147046243437,25026,29572,67843,50529,3136,2506,25011,26235,2690-10015,30919,1926,8596,7386,7506,7966,5616,5816,8706,8507,6422,5162,5162,48012,4532,5002,5002,5002,4003,5002,3002,6062,30710,0522,1722,1362,1096,3002,1002,0002,0000001,9000001,9000-100-1001,7000001,7000001,5000001,6000-1000-1000000000000000000000
   > Long-term Assets 
0
0
0
2,800
0
0
0
3,200
0
0
0
4,000
4,000
0
0
4,200
4,200
4,500
4,700
4,600
5,300
6,600
7,200
10,500
0
0
0
16,100
0
0
0
17,800
0
0
0
21,600
22,900
24,900
26,400
28,900
29,600
30,400
30,400
34,200
35,300
0
0
34,900
35,100
37,300
38,100
40,232
41,976
43,254
44,312
48,708
51,631
54,134
57,986
76,268
81,333
94,940
107,326
122,730
171,741
188,639
198,821
232,830
276,163
297,979
347,582
363,733
381,395
379,955
387,467
357,313
0
0
275,000
0
262,640
246,468
234,500
233,584
243,765
286,385
357,313
225,924
230,648
260,805
252,856
241,305
225,685
214,414
202,763
197,469
195,558
203,636
196,865
196,865
195,545
226,659
233,105
233,105
233,160
247,445
223,938
223,938
193,067
205,303
310,438
483,197
571,738
465,304
290,729
423,591
486,732
514,966
536,575
644,690
690,502
607,770
652,606
638,545
769,840
833,253
808,654
856,757
860,278
849,550
936,038
932,538
905,211
885,781
838,475
838,475
750,671
540,656
799,085
840,876
776,918
815,775
815,775776,918840,876799,085540,656750,671838,475838,475885,781905,211932,538936,038849,550860,278856,757808,654833,253769,840638,545652,606607,770690,502644,690536,575514,966486,732423,591290,729465,304571,738483,197310,438205,303193,067223,938223,938247,445233,160233,105233,105226,659195,545196,865196,865203,636195,558197,469202,763214,414225,685241,305252,856260,805230,648225,924357,313286,385243,765233,584234,500246,468262,6400275,00000357,313387,467379,955381,395363,733347,582297,979276,163232,830198,821188,639171,741122,730107,32694,94081,33376,26857,98654,13451,63148,70844,31243,25441,97640,23238,10037,30035,10034,9000035,30034,20030,40030,40029,60028,90026,40024,90022,90021,60000017,80000016,10000010,5007,2006,6005,3004,6004,7004,5004,2004,200004,0004,0000003,2000002,800000
       Property Plant Equipment 
0
0
0
2,000
0
0
0
2,400
0
0
0
2,500
2,600
0
0
2,900
2,800
3,100
3,300
3,600
4,400
5,400
6,300
9,400
0
0
0
11,100
0
0
0
13,000
0
0
0
16,200
17,500
19,700
21,200
23,700
24,400
25,300
25,400
28,700
30,000
0
0
29,600
29,900
32,200
32,600
34,624
36,392
37,699
38,693
41,827
44,814
47,318
48,943
54,024
60,383
67,171
78,858
93,358
118,445
140,290
156,112
182,306
208,959
220,018
230,322
241,966
257,935
260,383
266,080
269,419
219,753
216,570
211,900
0
196,466
186,543
183,111
182,406
185,159
176,168
269,419
172,212
171,210
163,596
161,671
159,424
154,565
152,532
150,750
147,779
146,812
145,762
145,265
145,265
145,527
150,960
151,416
151,416
154,199
153,488
153,045
153,045
151,053
153,343
159,459
164,598
171,427
173,446
180,085
183,415
187,937
190,468
193,727
194,797
198,097
197,896
206,242
205,654
206,727
206,692
209,961
209,228
207,923
206,296
205,508
202,031
196,632
193,995
199,692
199,692
191,489
190,507
190,139
189,590
189,893
218,385
218,385189,893189,590190,139190,507191,489199,692199,692193,995196,632202,031205,508206,296207,923209,228209,961206,692206,727205,654206,242197,896198,097194,797193,727190,468187,937183,415180,085173,446171,427164,598159,459153,343151,053153,045153,045153,488154,199151,416151,416150,960145,527145,265145,265145,762146,812147,779150,750152,532154,565159,424161,671163,596171,210172,212269,419176,168185,159182,406183,111186,543196,4660211,900216,570219,753269,419266,080260,383257,935241,966230,322220,018208,959182,306156,112140,290118,44593,35878,85867,17160,38354,02448,94347,31844,81441,82738,69337,69936,39234,62432,60032,20029,90029,6000030,00028,70025,40025,30024,40023,70021,20019,70017,50016,20000013,00000011,1000009,4006,3005,4004,4003,6003,3003,1002,8002,900002,6002,5000002,4000002,000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,007
0
0
0
3,839
0
0
0
7,150
0
0
0
7,199
0
0
0
7,222
0
0
0
7,232
7,231
0
7,300
0
0
7,217
0
0
0
7,265
7,232
0
0
7,285
0
0
0
7,277
7,284
0
0
0
7,277
7,277
0
0
7,248
7,248
0
0
7,206
7,206
0
0
7,198
0
0
0
7,192
0
0
0
7,201
0
0
0
7,191
0
0
0
7,191
0
0
0
7,191
0
0
0
11,820
11,820
12,718
12,718
17,231
17,231
17,231
17,231
17,23117,23117,23117,23112,71812,71811,82011,8200007,1910007,1910007,1910007,2010007,1920007,198007,2067,206007,2487,248007,2777,2770007,2847,2770007,285007,2327,2650007,217007,30007,2317,2320007,2220007,1990007,1500003,8390004,0070000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,894
0
0
0
30,175
0
0
0
115,173
284,000
366,438
258,685
70,685
71,000
0
0
225,639
298,145
335,710
260,426
304,322
291,544
417,778
479,050
459,639
510,397
476,800
476,248
557,209
568,878
552,939
536,348
435,189
374,968
357,586
0
404,896
451,174
388,370
403,544
403,544388,370451,174404,8960357,586374,968435,189536,348552,939568,878557,209476,248476,800510,397459,639479,050417,778291,544304,322260,426335,710298,145225,6390071,00070,685258,685366,438284,000115,17300030,17500052,894000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
700
0
0
0
700
0
0
0
700
1,400
0
0
700
1,300
1,300
1,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,885
0
0
0
6,252
0
0
0
14,826
0
0
0
37,386
0
0
0
70,396
0
0
0
65,256
35,874
0
26,400
0
0
23,756
0
0
0
20,883
60,673
0
0
22,771
0
0
0
19,172
18,308
0
0
0
15,595
15,595
0
0
16,614
16,614
0
0
13,204
13,204
0
0
22,372
0
0
0
19,867
0
0
0
20,801
0
0
0
22,332
0
0
0
21,662
0
0
0
19,786
0
0
0
60,124
60,124
0
0
76,144
0
0
0
00076,1440060,12460,12400019,78600021,66200022,33200020,80100019,86700022,3720013,20413,2040016,61416,6140015,59515,59500018,30819,17200022,7710060,67320,88300023,7560026,400035,87465,25600070,39600037,38600014,8260006,2520004,8850000000000000000000000000000000000001,3001,3001,300700001,400700000700000700000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,355
0
0
0
0
0
0
0
5,584
5,555
5,619
6,881
0
0
0
22,244
20,950
27,769
28,468
29,372
53,296
48,349
42,709
50,524
67,204
77,961
117,260
121,767
123,460
119,572
121,387
87,894
71,540
76,433
63,003
0
66,174
59,925
51,389
51,178
58,606
110,217
54,729
53,712
59,438
97,209
91,185
81,881
71,120
61,882
52,013
49,690
48,746
57,874
51,600
50,728
50,018
75,699
81,689
97,121
78,961
93,957
70,893
65,165
42,014
51,960
150,979
318,599
400,311
291,858
110,644
240,176
298,795
324,498
102,916
151,748
156,695
149,448
142,042
141,347
145,335
147,511
121,256
137,132
175,555
167,006
156,635
161,629
155,640
155,438
139,019
189,234
188,878
186,758
0
0
181,424
0
0181,42400186,758188,878189,234139,019155,438155,640161,629156,635167,006175,555137,132121,256147,511145,335141,347142,042149,448156,695151,748102,916324,498298,795240,176110,644291,858400,311318,599150,97951,96042,01465,16570,89393,95778,96197,12181,68975,69950,01850,72851,60057,87448,74649,69052,01361,88271,12081,88191,18597,20959,43853,71254,729110,21758,60651,17851,38959,92566,174063,00376,43371,54087,894121,387119,572123,460121,767117,26077,96167,20450,52442,70948,34953,29629,37228,46827,76920,95022,2440006,8815,6195,5555,58400000005,35500000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
5,800
0
0
0
6,400
0
0
0
7,500
6,700
0
0
9,300
8,500
8,100
8,400
9,400
7,700
9,000
11,000
15,100
0
0
0
16,200
0
0
0
20,900
0
0
0
25,400
28,000
31,900
32,300
35,500
37,400
39,500
43,000
45,700
49,800
0
0
45,700
45,600
53,400
56,400
50,257
53,740
55,527
68,705
70,064
71,324
81,691
85,419
88,622
87,493
97,537
95,941
109,549
141,941
191,791
205,232
267,412
280,770
284,283
301,689
328,033
318,442
324,141
325,418
342,146
374,907
304,466
330,100
0
301,156
308,881
268,528
266,869
296,033
280,193
342,146
264,158
247,699
171,929
177,019
177,269
210,956
224,782
233,466
191,298
205,199
197,202
215,675
215,675
249,901
255,160
263,783
263,783
244,987
276,587
320,362
320,362
285,619
295,013
250,889
248,895
231,152
244,920
215,947
211,762
206,316
218,415
222,811
197,825
207,717
223,999
224,204
197,355
218,400
222,359
231,494
705,555
627,363
621,251
711,416
755,249
644,050
426,465
464,918
464,918
400,999
397,589
404,655
396,517
371,917
384,086
384,086371,917396,517404,655397,589400,999464,918464,918426,465644,050755,249711,416621,251627,363705,555231,494222,359218,400197,355224,204223,999207,717197,825222,811218,415206,316211,762215,947244,920231,152248,895250,889295,013285,619320,362320,362276,587244,987263,783263,783255,160249,901215,675215,675197,202205,199191,298233,466224,782210,956177,269177,019171,929247,699264,158342,146280,193296,033266,869268,528308,881301,1560330,100304,466374,907342,146325,418324,141318,442328,033301,689284,283280,770267,412205,232191,791141,941109,54995,94197,53787,49388,62285,41981,69171,32470,06468,70555,52753,74050,25756,40053,40045,60045,7000049,80045,70043,00039,50037,40035,50032,30031,90028,00025,40000020,90000016,20000015,10011,0009,0007,7009,4008,4008,1008,5009,300006,7007,5000006,4000005,800000
   > Total Current Liabilities 
0
0
0
2,700
0
0
0
2,900
0
0
0
4,100
4,000
0
0
5,700
5,800
6,700
7,200
6,800
6,400
7,000
9,300
11,100
0
0
0
13,500
0
0
0
18,900
0
0
0
13,500
15,000
17,400
17,800
20,200
21,600
23,200
26,900
28,500
32,600
0
0
27,800
27,700
33,200
27,400
24,761
28,987
28,176
34,325
28,150
27,653
30,390
30,597
34,783
32,375
44,276
41,803
58,244
80,283
75,976
94,003
103,738
100,988
95,638
106,651
131,529
126,075
136,643
127,289
170,285
263,579
200,940
232,900
200,200
206,312
239,403
185,178
193,059
225,503
230,409
170,285
214,972
195,107
129,786
134,444
132,362
173,006
190,383
198,899
158,111
172,189
173,842
192,531
192,531
227,390
243,933
253,304
253,304
234,684
266,521
310,005
310,005
275,970
290,418
245,462
243,378
225,972
239,463
209,837
205,767
201,546
213,573
215,756
192,629
203,059
218,639
216,821
189,233
209,501
214,179
222,731
596,487
587,316
584,077
676,301
729,150
613,958
394,793
432,119
432,119
374,851
374,075
385,549
385,006
361,488
374,059
374,059361,488385,006385,549374,075374,851432,119432,119394,793613,958729,150676,301584,077587,316596,487222,731214,179209,501189,233216,821218,639203,059192,629215,756213,573201,546205,767209,837239,463225,972243,378245,462290,418275,970310,005310,005266,521234,684253,304253,304243,933227,390192,531192,531173,842172,189158,111198,899190,383173,006132,362134,444129,786195,107214,972170,285230,409225,503193,059185,178239,403206,312200,200232,900200,940263,579170,285127,289136,643126,075131,529106,65195,638100,988103,73894,00375,97680,28358,24441,80344,27632,37534,78330,59730,39027,65328,15034,32528,17628,98724,76127,40033,20027,70027,8000032,60028,50026,90023,20021,60020,20017,80017,40015,00013,50000018,90000013,50000011,1009,3007,0006,4006,8007,2006,7005,8005,700004,0004,1000002,9000002,700000
       Short-term Debt 
0
0
0
1,200
0
0
0
1,100
0
0
0
2,000
1,400
0
0
2,300
1,900
2,000
2,600
3,000
1,500
2,600
4,600
5,500
0
0
0
7,500
0
0
0
10,300
0
0
0
5,000
5,900
7,000
6,900
9,000
11,300
11,900
12,500
13,700
16,600
0
0
16,600
16,400
17,100
14,100
11,396
15,192
13,640
17,050
8,491
10,009
10,829
8,228
2,221
3,887
16,686
9,742
10,272
22,997
23,217
22,445
43,544
18,870
33,254
44,781
81,905
74,483
67,282
83,135
107,277
0
0
109,000
0
125,414
130,004
118,971
115,191
126,311
125,367
107,277
105,776
91,689
28,195
30,909
27,364
25,846
17,073
10,957
10,566
10,685
11,086
11,330
11,330
11,880
12,084
11,974
11,974
11,478
898
912
912
940
0
-60,184
0
0
0
-52,398
0
-201,546
0
0
-87,257
0
0
-9,439
0
0
0
1,514
-105,389
-143,297
0
1,689
-130,832
-125,449
-125,659
2,204
2,204
0
0
1,950
0
0
0
0001,950002,2042,204-125,659-125,449-130,8321,6890-143,297-105,3891,514000-9,43900-87,25700-201,5460-52,398000-60,184094091291289811,47811,97411,97412,08411,88011,33011,33011,08610,68510,56610,95717,07325,84627,36430,90928,19591,689105,776107,277125,367126,311115,191118,971130,004125,4140109,00000107,27783,13567,28274,48381,90544,78133,25418,87043,54422,44523,21722,99710,2729,74216,6863,8872,2218,22810,82910,0098,49117,05013,64015,19211,39614,10017,10016,40016,6000016,60013,70012,50011,90011,3009,0006,9007,0005,9005,00000010,3000007,5000005,5004,6002,6001,5003,0002,6002,0001,9002,300001,4002,0000001,1000001,200000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,603
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,664
0
0
0
912
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000091200018,66400000000000000000000000000000000000000000000000000000000016,60300000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
2,600
0
0
0
3,800
4,700
4,600
3,900
4,900
4,400
4,700
5,500
0
0
0
5,600
0
0
0
7,600
0
0
0
8,400
9,100
10,300
10,900
10,300
10,200
11,300
14,500
14,000
16,000
0
0
10,000
11,400
16,000
13,300
5,376
13,795
14,536
17,275
8,916
17,644
19,561
22,369
26,552
22,122
27,590
32,061
25,216
57,286
52,759
50,450
26,148
58,871
50,964
44,206
17,845
51,592
50,036
44,154
63,008
18,442
73,290
20,300
0
80,898
25,877
66,207
77,868
99,192
27,979
108,341
109,196
103,418
21,905
103,535
104,998
147,160
23,321
22,977
147,500
161,500
162,756
181,201
181,201
215,510
231,849
241,330
241,330
223,206
265,623
309,093
309,093
275,030
290,418
245,462
243,378
225,972
239,463
209,837
205,767
201,546
23,885
25,697
26,513
30,207
32,500
35,060
37,210
38,409
37,035
28,858
36,302
39,967
45,409
61,166
62,066
55,228
43,685
68,232
68,232
61,356
69,549
68,485
59,368
43,059
51,183
51,18343,05959,36868,48569,54961,35668,23268,23243,68555,22862,06661,16645,40939,96736,30228,85837,03538,40937,21035,06032,50030,20726,51325,69723,885201,546205,767209,837239,463225,972243,378245,462290,418275,030309,093309,093265,623223,206241,330241,330231,849215,510181,201181,201162,756161,500147,50022,97723,321147,160104,998103,53521,905103,418109,196108,34127,97999,19277,86866,20725,87780,898020,30073,29018,44263,00844,15450,03651,59217,84544,20650,96458,87126,14850,45052,75957,28625,21632,06127,59022,12226,55222,36919,56117,6448,91617,27514,53613,7955,37613,30016,00011,40010,0000016,00014,00014,50011,30010,20010,30010,90010,3009,1008,4000007,6000005,6000005,5004,7004,4004,9003,9004,6004,7003,8000002,600000000000000
       Other Current Liabilities 
0
0
0
1,500
0
0
0
1,800
0
0
0
2,100
0
0
0
3,400
100
0
0
-100
0
0
0
100
0
0
0
400
0
0
0
1,000
0
0
0
100
0
100
0
900
100
0
-100
800
0
0
0
1,200
-100
100
13,300
7,989
13,808
14,560
17,250
3,525
17,691
19,571
22,372
6,010
6,366
27,614
32,058
22,756
57,303
52,783
21,108
24,823
23,247
11,420
17,664
50,601
51,617
19,325
44,165
-31,387
91,220
0
98,014
0
80,898
83,522
66,207
77,868
99,192
73,250
62,546
109,196
103,418
79,686
0
0
0
149,348
164,506
147,545
161,504
-86
-351
-351
20
16
-19,917
-19,917
223,206
2
-79
-79
275,030
0
59,385
0
0
0
52,231
0
-125,597
189,688
190,059
166,116
172,852
186,139
181,761
152,023
171,092
177,144
192,122
560,185
547,349
538,668
605,863
667,084
558,730
351,108
355,895
355,895
313,495
304,526
314,211
325,638
318,429
322,876
322,876318,429325,638314,211304,526313,495355,895355,895351,108558,730667,084605,863538,668547,349560,185192,122177,144171,092152,023181,761186,139172,852166,116190,059189,688-125,597052,23100059,3850275,030-79-792223,206-19,917-19,9171620-351-351-86161,504147,545164,506149,34800079,686103,418109,19662,54673,25099,19277,86866,20783,52280,898098,014091,220-31,38744,16519,32551,61750,60117,66411,42023,24724,82321,10852,78357,30322,75632,05827,6146,3666,01022,37219,57117,6913,52517,25014,56013,8087,98913,300100-1001,200000800-1000100900010001000001,000000400000100000-100001003,4000002,1000001,8000001,500000
   > Long-term Liabilities 
0
0
0
3,100
0
0
0
3,500
0
0
0
3,400
2,700
0
0
3,600
2,700
1,400
1,200
2,600
1,300
2,000
1,700
4,000
0
0
0
2,700
0
0
0
2,000
0
0
0
11,900
13,000
14,500
14,500
15,300
15,800
16,300
16,100
17,200
17,200
0
0
17,900
17,900
20,200
29,000
25,496
24,753
27,351
34,380
41,914
43,671
51,301
54,822
53,839
55,118
53,261
54,138
51,305
61,658
115,815
111,229
163,674
179,782
188,645
195,038
196,504
192,367
187,498
198,129
171,861
0
0
97,200
0
94,844
69,478
83,350
73,810
70,530
49,784
171,861
49,186
52,592
42,143
42,575
44,907
37,950
34,399
34,567
33,187
33,010
23,360
23,144
23,144
22,511
11,227
10,479
10,479
10,303
10,066
10,357
10,357
9,649
4,595
5,427
5,517
5,180
5,457
6,110
5,995
4,770
4,842
7,055
5,196
4,658
5,360
7,383
8,122
8,899
8,180
8,763
109,068
40,047
37,174
35,115
26,099
30,092
31,672
32,799
32,799
26,148
-69,549
19,106
11,511
10,429
10,027
10,02710,42911,51119,106-69,54926,14832,79932,79931,67230,09226,09935,11537,17440,047109,0688,7638,1808,8998,1227,3835,3604,6585,1967,0554,8424,7705,9956,1105,4575,1805,5175,4274,5959,64910,35710,35710,06610,30310,47910,47911,22722,51123,14423,14423,36033,01033,18734,56734,39937,95044,90742,57542,14352,59249,186171,86149,78470,53073,81083,35069,47894,844097,20000171,861198,129187,498192,367196,504195,038188,645179,782163,674111,229115,81561,65851,30554,13853,26155,11853,83954,82251,30143,67141,91434,38027,35124,75325,49629,00020,20017,90017,9000017,20017,20016,10016,30015,80015,30014,50014,50013,00011,9000002,0000002,7000004,0001,7002,0001,3002,6001,2001,4002,7003,600002,7003,4000003,5000003,100000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,145
0
0
0
0
0
0
0
2,261
2,183
2,131
1,164
3,564
0
4,136
1,145
4,510
4,696
4,732
1,398
4,240
4,483
4,437
1,857
6,615
6,838
7,060
2,442
192,367
8,003
10,879
4,931
15,435
7,427
15,299
0
8,365
7,666
83,350
73,810
70,530
7,591
11,060
37,591
12,479
8,576
10,491
11,839
7,258
4,934
6,618
6,240
6,049
6,116
3,996
5,623
5,139
5,120
2,852
4,667
4,864
4,857
3,480
5,260
5,150
4,595
3,195
5,517
5,180
5,457
3,996
5,995
4,770
4,842
7,055
5,196
4,658
5,360
7,383
8,122
8,899
8,180
7,610
109,068
40,047
37,174
33,788
26,099
30,092
31,672
28,841
31,826
26,148
23,514
0
0
10,429
0
010,4290023,51426,14831,82628,84131,67230,09226,09933,78837,17440,047109,0687,6108,1808,8998,1227,3835,3604,6585,1967,0554,8424,7705,9953,9965,4575,1805,5173,1954,5955,1505,2603,4804,8574,8644,6672,8525,1205,1395,6233,9966,1166,0496,2406,6184,9347,25811,83910,4918,57612,47937,59111,0607,59170,53073,81083,3507,6668,365015,2997,42715,4354,93110,8798,003192,3672,4427,0606,8386,6151,8574,4374,4834,2401,3984,7324,6964,5101,1454,13603,5641,1642,1312,1832,261000000016,14500000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,069
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
0
0
0
1,901
0
0
0
2,232
0
0
0
2,114
0
0
0
3,228
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000003,2280002,1140002,2320001,901000280000000000000000000000000000000000000000000000000000000001,06900000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
1,500
0
0
0
1,500
0
0
0
2,100
1,800
0
0
1,900
2,300
3,400
4,000
4,800
9,600
10,000
10,500
10,000
0
0
0
17,600
0
0
0
21,800
0
0
0
24,100
24,300
24,800
25,700
26,300
26,300
26,700
27,500
27,300
27,400
0
0
28,800
29,900
31,300
33,100
40,552
42,048
43,811
46,388
50,214
52,258
59,097
66,392
218,364
228,310
239,525
249,906
269,137
286,549
304,924
320,327
347,400
356,919
349,850
357,331
368,120
374,112
377,736
384,144
236,865
49,783
181,985
153,200
197,900
206,042
164,217
198,592
211,072
228,688
292,968
236,865
256,096
297,508
381,312
417,066
455,411
499,109
567,264
619,008
680,678
756,842
843,391
886,347
886,347
1,036,943
944,697
1,015,507
1,015,507
1,197,431
1,316,794
1,411,719
1,411,719
1,610,032
1,769,522
1,931,142
1,913,429
1,913,385
1,995,923
2,067,494
2,139,515
2,201,042
2,198,374
2,205,158
2,274,672
2,342,409
1,839,976
1,905,536
1,969,201
2,025,630
2,062,934
2,103,862
1,683,279
1,727,957
1,759,668
1,703,649
1,658,056
1,673,108
1,696,554
1,711,443
1,711,443
1,706,280
1,719,935
1,730,858
1,738,532
1,747,556
1,779,093
1,779,0931,747,5561,738,5321,730,8581,719,9351,706,2801,711,4431,711,4431,696,5541,673,1081,658,0561,703,6491,759,6681,727,9571,683,2792,103,8622,062,9342,025,6301,969,2011,905,5361,839,9762,342,4092,274,6722,205,1582,198,3742,201,0422,139,5152,067,4941,995,9231,913,3851,913,4291,931,1421,769,5221,610,0321,411,7191,411,7191,316,7941,197,4311,015,5071,015,507944,6971,036,943886,347886,347843,391756,842680,678619,008567,264499,109455,411417,066381,312297,508256,096236,865292,968228,688211,072198,592164,217206,042197,900153,200181,98549,783236,865384,144377,736374,112368,120357,331349,850356,919347,400320,327304,924286,549269,137249,906239,525228,310218,36466,39259,09752,25850,21446,38843,81142,04840,55233,10031,30029,90028,8000027,40027,30027,50026,70026,30026,30025,70024,80024,30024,10000021,80000017,60000010,00010,50010,0009,6004,8004,0003,4002,3001,900001,8002,1000001,5000001,500000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
680
0
0
0
680
0
0
0
680
0
0
0
680
0
0
0
680
0
0
0
680
0
0
0
679
680
0
680
0
0
680
0
0
0
680
0
0
0
679
0
0
0
679
679
0
0
0
680
680
0
0
680
680
0
0
680
680
0
0
680
1,913,000
1,913,385
1,995,923
680
2,139,515
2,201,042
2,198,374
680
2,274,672
2,342,409
1,839,976
680
1,969,201
2,025,630
2,062,934
679
1,683,279
1,727,957
1,759,668
679
1,658,056
1,673,108
1,696,554
680
680
1,706,280
1,719,935
680
1,738,532
1,747,556
0
01,747,5561,738,5326801,719,9351,706,2806806801,696,5541,673,1081,658,0566791,759,6681,727,9571,683,2796792,062,9342,025,6301,969,2016801,839,9762,342,4092,274,6726802,198,3742,201,0422,139,5156801,995,9231,913,3851,913,000680006806800068068000680680000679679000679000680000680006800680679000680000680000680000680000680000680000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,200
-868
22,477
22,166
21,932
-1,381
21,518
22,296
22,253
218,364
228,310
239,525
249,906
-2,358
174,041
177,598
177,265
5,695
186,126
187,916
191,368
13,477
374,112
377,736
200,830
11,811
0
0
306,400
0
0
7,722
0
0
0
21,980
586,000
0
0
24,186
0
0
0
18,549
23,034
1,361,400
1,513,600
1,686,800
16,743
16,743
2,073,800
1,889,400
-22,896
-22,896
2,394,800
2,633,600
-110,966
-110,966
3,220,000
3,539,000
-123,026
3,826,800
3,826,800
3,991,800
-148,133
4,279,000
4,402,000
4,396,800
-110,285
4,549,400
4,684,800
3,679,952
-144,108
3,938,402
4,051,260
4,125,868
-163,037
3,366,558
0
0
-151,621
0
0
0
-168,965
-168,965
0
0
-174,996
0
0
0
000-174,99600-168,965-168,965000-151,621003,366,558-163,0374,125,8684,051,2603,938,402-144,1083,679,9524,684,8004,549,400-110,2854,396,8004,402,0004,279,000-148,1333,991,8003,826,8003,826,800-123,0263,539,0003,220,000-110,966-110,9662,633,6002,394,800-22,896-22,8961,889,4002,073,80016,74316,7431,686,8001,513,6001,361,40023,03418,54900024,18600586,00021,9800007,72200306,4000011,811200,830377,736374,11213,477191,368187,916186,1265,695177,265177,598174,041-2,358249,906239,525228,310218,36422,25322,29621,518-1,38121,93222,16622,477-86866,20000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000-610,009000-498,675000-203,778000-194,328000-194,328000-1,3290000-1,329000-1,329000-1,329000-1,32900-1,3610-1,388-1,387000-1,348000-1,348000-1,288000-1,28800000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
2,100
0
0
0
2,000
0
0
0
2,800
2,500
0
0
2,800
3,200
4,300
4,900
0
0
0
0
9,100
0
0
0
16,500
0
0
0
17,300
0
0
0
17,600
17,600
17,500
17,700
17,600
17,500
17,500
17,600
17,200
0
0
0
16,400
16,700
16,700
-49,300
-40,600
-42,000
-43,800
-46,400
-50,200
-52,300
-59,100
-66,400
-218,400
-228,300
-239,500
-249,900
172,296
112,459
127,302
143,035
181,351
170,774
161,984
165,932
183,214
0
0
183,270
162,383
0
0
-57,685
0
206,042
220,809
198,592
211,072
228,688
221,279
174,873
256,096
297,508
243,340
417,066
455,411
499,109
252,248
252,255
-680,722
-756,758
-843,409
259,679
259,679
-1,036,857
-944,703
68,091
68,091
-1,197,369
-1,316,806
68,117
68,117
-1,609,968
-1,769,478
58,667
-1,913,371
-1,913,415
-1,995,877
-236,230
-2,139,485
-2,200,958
-2,198,426
-347,564
-2,274,728
-2,342,391
-1,839,976
-432,065
-1,969,201
-2,025,630
-2,062,934
-459,048
-1,683,279
1,727,957
1,759,668
-484,026
1,658,056
1,673,108
1,696,554
-508,963
-508,963
0
-1,719,935
-508,962
0
0
0
000-508,962-1,719,9350-508,963-508,9631,696,5541,673,1081,658,056-484,0261,759,6681,727,957-1,683,279-459,048-2,062,934-2,025,630-1,969,201-432,065-1,839,976-2,342,391-2,274,728-347,564-2,198,426-2,200,958-2,139,485-236,230-1,995,877-1,913,415-1,913,37158,667-1,769,478-1,609,96868,11768,117-1,316,806-1,197,36968,09168,091-944,703-1,036,857259,679259,679-843,409-756,758-680,722252,255252,248499,109455,411417,066243,340297,508256,096174,873221,279228,688211,072198,592220,809206,0420-57,68500162,383183,27000183,214165,932161,984170,774181,351143,035127,302112,459172,296-249,900-239,500-228,300-218,400-66,400-59,100-52,300-50,200-46,400-43,800-42,000-40,600-49,30016,70016,70016,40000017,20017,60017,50017,50017,60017,70017,50017,60017,60000017,30000016,5000009,10000004,9004,3003,2002,800002,5002,8000002,0000002,100000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue572,952
Cost of Revenue-304,629
Gross Profit268,323268,323
 
Operating Income (+$)
Gross Profit268,323
Operating Expense-250,609
Operating Income17,71417,714
 
Operating Expense (+$)
Research Development52,243
Selling General Administrative85,086
Selling And Marketing Expenses113,280
Operating Expense250,609250,609
 
Net Interest Income (+$)
Interest Income20,850
Interest Expense-17,686
Other Finance Cost-17,686
Net Interest Income20,850
 
Pretax Income (+$)
Operating Income17,714
Net Interest Income20,850
Other Non-Operating Income Expenses0
Income Before Tax (EBT)38,213-2,785
EBIT - interestExpense = 28
38,213
43,131
Interest Expense17,686
Earnings Before Interest and Taxes (EBIT)17,71455,899
Earnings Before Interest and Taxes (EBITDA)52,654
 
After tax Income (+$)
Income Before Tax38,213
Tax Provision-12,768
Net Income From Continuing Ops25,44525,445
Net Income25,445
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses555,238
Total Other Income/Expenses Net20,499-20,850
 

Technical Analysis of Taro
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Taro. The general trend of Taro is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Taro's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Taro Pharmaceutical Industries Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 45.76.

The bearish price targets are: 42.24 > 40.80 > 40.67.

Tweet this
Taro Pharmaceutical Industries Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Taro Pharmaceutical Industries Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Taro Pharmaceutical Industries Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Taro Pharmaceutical Industries Ltd. The current macd is 0.03770995.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Taro price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Taro. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Taro price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Taro Pharmaceutical Industries Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTaro Pharmaceutical Industries Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Taro Pharmaceutical Industries Ltd. The current adx is 18.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Taro shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Taro Pharmaceutical Industries Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Taro Pharmaceutical Industries Ltd. The current sar is 41.29.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Taro Pharmaceutical Industries Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Taro Pharmaceutical Industries Ltd. The current rsi is 53.58. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Taro Pharmaceutical Industries Ltd Daily Relative Strength Index (RSI) ChartTaro Pharmaceutical Industries Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Taro Pharmaceutical Industries Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Taro price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Taro Pharmaceutical Industries Ltd Daily Stochastic Oscillator ChartTaro Pharmaceutical Industries Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Taro Pharmaceutical Industries Ltd. The current cci is 98.61.

Taro Pharmaceutical Industries Ltd Daily Commodity Channel Index (CCI) ChartTaro Pharmaceutical Industries Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Taro Pharmaceutical Industries Ltd. The current cmo is 10.39.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Taro Pharmaceutical Industries Ltd Daily Chande Momentum Oscillator (CMO) ChartTaro Pharmaceutical Industries Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Taro Pharmaceutical Industries Ltd. The current willr is -33.96226415.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Taro is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Taro Pharmaceutical Industries Ltd Daily Williams %R ChartTaro Pharmaceutical Industries Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Taro Pharmaceutical Industries Ltd. The current atr is 0.33033667.

Taro Pharmaceutical Industries Ltd Daily Average True Range (ATR) ChartTaro Pharmaceutical Industries Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Taro Pharmaceutical Industries Ltd. The current obv is 2,335,852.

Taro Pharmaceutical Industries Ltd Daily On-Balance Volume (OBV) ChartTaro Pharmaceutical Industries Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Taro Pharmaceutical Industries Ltd. The current mfi is 62.35.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Taro Pharmaceutical Industries Ltd Daily Money Flow Index (MFI) ChartTaro Pharmaceutical Industries Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Taro Pharmaceutical Industries Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Taro Pharmaceutical Industries Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Taro Pharmaceutical Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.576
Ma 20Greater thanMa 5042.050
Ma 50Greater thanMa 10042.270
Ma 100Greater thanMa 20040.448
OpenGreater thanClose42.240
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Taro with someone you think should read this too:
  • Are you bullish or bearish on Taro? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Taro? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Taro Pharmaceutical Industries Ltd

I send you an email if I find something interesting about Taro Pharmaceutical Industries Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Taro Pharmaceutical Industries Ltd.

Receive notifications about Taro Pharmaceutical Industries Ltd in your mailbox!